From: Evaluation of glycemic abnormalities in children and adolescents with β-thalassemia major
Variable | Patients (N = 40) | Controls (N = 30) | St. “t” | P | |||||
---|---|---|---|---|---|---|---|---|---|
Mean | ± SD | Range | Mean | ± SD | Range | ||||
Age (years) | 11.0 | 2.86 | 8-16 | 10.8 | 2.49 | 8-16 | 0.31 | 0.75 | |
Sex (no., %) | Male | 27 (67.5%) | 18 (60%) | χ2 (0.42) | 0.51 | ||||
Female | 13 (32.5%) | 12 (40%) | |||||||
BMI (kg/m2) | 20.1 | 5.47 | 13.6-40.4 | 19.6 | 2.98 | 15.4-24.8 | 0.43 | 0.66 (NS) | |
Hb% | 8.49 | 1.15 | 6.3-10.0 | 10.68 | 1.34 | 8.4-13.0 | 7.34 | < 0.001 (HS) | |
ALT (U/L) | 55.5 | 15.4 | 35-96 | 48.3 | 4.22 | 41-59 | 2.47 | 0.016 (S) | |
AST (U/L) | 51.8 | 12.3 | 35-95 | 43.9 | 5.0 | 34-53 | 3.31 | 0.002 (S) | |
S ferritin (ng/ml) | 2808.1 | 1344.0 | 1103-6989 | 20 | 3.0 | 30-18 | 4.05 | < 0.001 (HS) | |
Fasting plasma glucose (mg/dl) | 104.7 | 21.0 | 70-151 | 90.4 | 11.9 | 74-108 | 3.1 | 0.002 (S) | |
Fasting plasma insulin (μU/ml) | 10.9 | 14.8 | 2.62-74.9 | 8.0 | 7.1 | 2.98-43.7 | 0.99 | 0.32 | |
2 h pp plasma glucose (mg/dl) | 157.0 | 32.2 | 99-225 | 114.5 | 10.5 | 95-130 | St. “t” = 6.94 | < 0.001 (HS) | |
HOMA-IR% | 3.21 | 4.77 | 0.66-27.9 | 1.51 | 0.49 | 0.55-2.39 | 2.43 | 0.015 (S) | |
IR (no., %) | No | 29 (72.5%) | 30 (100%) | 0.002 (S) | |||||
Yes | 11 (27.5%) | 0 (0%) |